None listed
Conditions
Interventions
Intervention1: Reservatrol tablet: Reservatrol tablet Once daily for 12 weeks, subject age more than 18 years
Control Intervention1: NA: Na
Sponsors
Apex laboratories private limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age more than 18 years 2.Patient seeking for complexion improvement and antiageing treatment 3.Willingness to not to go for any facial parlor or cosmetic procedures during the study 4.Willingness to not to use any oral nutritional supplements and/or vitamin supplementation
Exclusion criteria
Exclusion criteria: 1.Pregnancy and lactation 2.History of allergy or hypersensitivity to product or any components
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wrinkles will be assessed by ANTERA 3D, sagging will be assessed by clinically, skin radiance is assessed by clinical scoring using the coloring, luminosity, brightness, and transparency (C.L.B.T.) scale and imperfections scale (dark circles, redness/rosacea, spots, and heterogeneity)Timepoint: After 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Wrinkles will be assessed by ANTERA 3D, sagging will be assessed by clinically, skin radiance is assessed by clinical scoring using the coloring, luminosity, brightness, and transparency (C.L.B.T.) scale and imperfections scale (dark circles, redness/rosacea, spots, and heterogeneity)Timepoint: After 3 months | — |
Countries
India
Contacts
Public ContactDr Chaithra Shenoy
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed